Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: A double-blind-placebo-controlled randomised trial

Respiratory Medicine

Volumn 107, Issue 9, 2013, Pages 1322-1329

  Aydogan, Metin ^a   Eifan, Aarif O ^a,b   Keles, Sevgi ^a   Akkoc, Tunc ^a   Nursoy, Mustafa A ^a   Bahceciler, Nerrin N ^a,c   Barlan, Isil B ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NEAR EAST UNIVERSITY   (Turkey)

Author keywords

Allergy; Asthma; Conjunctivitis; Dust mite; immunotherapy; Rhinitis; Sublingual

Indexed keywords

HOUSE DUST ALLERGEN; PLACEBO;

ARTICLE; BRONCHUS HYPERREACTIVITY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONJUNCTIVITIS; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; EPIPHORA; HAY FEVER; HUMAN; LUNG FUNCTION; NASAL PRURITUS; NAUSEA; NOSE PROVOCATION TEST; OCULAR PRURITUS; PRESCHOOL CHILD; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINOCONJUNCTIVITIS; RHINORRHEA; SCHOOL CHILD; SKIN TEST; SUBLINGUAL IMMUNOTHERAPY; SYMPTOM; VOMITING;

AIT; ALLERGEN IMMUNOTHERAPY; ALLERGIC RHINITIS; ALLERGY; AR; ASTHMA; CONJUNCTIVITIS; DER F; DER P; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DUST MITE; HDM; HOUSE-DUST-MITE; ICS; INHALED CORTICOSTEROIDS; MBHR; METHACHOLINE-NON-SPECIFIC BRONCHIAL HYPERREACTIVITY; RHINITIS; SCIT; SLIT; SNPT; SPECIFIC ALLERGEN-HDM NASAL PROVOCATION; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY;

ALLERGENS; ANIMALS; CHILD; CHILD, PRESCHOOL; CONJUNCTIVITIS, ALLERGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NASAL PROVOCATION TESTS; PROSPECTIVE STUDIES; PYROGLYPHIDAE; RESPIRATORY FUNCTION TESTS; RHINITIS, ALLERGIC, PERENNIAL; SKIN TESTS; SUBLINGUAL IMMUNOTHERAPY; TREATMENT OUTCOME;

EID: 84883053892     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.06.021     Document Type: Article

References (36)

1. W. Eder, M.J. Ege, and E. von Mutius The asthma epidemic N Engl J Med 355 2006 2226 2235
2. T. Platts-Mills, A.L. de Weck, and R. Aalberse J Allergy Clin Immunol 83 2 Pt 1 1989 Feb 416 427
3. A. Sheikh, B. Hurwitz, U. Nurmatov, and C.P. van Schayck House dust mite avoidance measures for perennial allergic rinitis Cochrane Database Syst Rev 7 2010 Jul 7 CD001563
4. P.C. Gøtzsche, and H.K. Johansen House dust mite control measures for asthma Cochrane Database Syst Rev 2 2008 Apr 16 CD001187
5. L.B. Bacharier, A. Boner, and K.H. Carlsen Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report Allergy 63 2008 5 34
6. H. Ott, J. Sieber, and R. Brehler Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study Allergy 64 2009 1394 1401
7. U. Wahn, A. Tabar, and P. Kuna Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis J Allergy Clin Immunol 123 2009 160 166
8. S. Halken, L. Agertoft, and J. Seidenberg Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents Pediatr Allergy Immunol 21 2010 970 976
9. E. Compalati, G. Passalacqua, M. Bonini, and G.W. Canonica The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis Allergy 64 11 2009 Nov 1570 1579
10. B. Mortemousque, F. Bertel, J. De Casamayor, P. Verin, and J. Colin House-dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study Clin Exp Allergy 33 4 2003 Apr 464 469
11. J. Bousquet, P. Van Cauwenberge, and N. Khaltaev Allergic rhinitis and its impact on asthma J Allergy Clin Immunol 108 5 Suppl 2001 Nov S147 S334
12. Global Initiative for Asthma Global strategy for asthma management and prevention 2002 National Institutes of Health Publication no. 02-3659
13. E. Alvarez-Cuesta, J. Bousquet, G.W. Canonica, S.R. Durham, H.J. Malling, and E. Valovirta EAACI, Immunotherapy Task Force. Standards for practical allergen-specific immunotherapy Allergy 61 Suppl. 82 2006 1 20
14. R.O. Crapo, R. Casaburi, and A.L. Coates Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999 Am J Respir Crit Care Med 161 1 2000 309 329
15. M. Kulig, U. Klettke, V. Wahn, J. Forster, C.P. Bauer, and U. Wahn Development of seasonal allergic rhinitis during the first 7 years of life J Allergy Clin Immunol 106 5 2000 832 839
16. D.J. Stoltz, D.J. Jackson, M.D. Evans, R.E. Gangnon, C.J. Tisler, and J.E. Gern Specific patterns of allergic sensitization in early childhood and asthma & rhinitis risk Clin Exp Allergy 43 2 2013 Feb 233 241
17. M.A. Calderon, R. Gerth van Wijk, and I. Eichler Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement Pediatr Allergy Immunol 23 4 2012 300 306
18. N.N. Bahçeciler, U. Işik, I.B. Barlan, and M.M. Başaran Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study Pediatr Pulmonol 32 1 2001 49 55
19. T. Hirsch, M. Sahn, and W. Leupold Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children Pediatr Allergy Immunol 8 1997 21 27
20. N. Pham-Thi, P. Scheinmann, and R. Fadel Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures Pediatr Allergy Immunol 18 2007 47 57
21. C.M. de Bot, H. Moed, M.Y. Berger, E. Röder, W.C. Hop, and H. de Groot Sublingual immunotherapy not effective in house dust mite-allergic children in primary care Pediatr Allergy Immunol 23 2 2012 Mar 150 158
22. S. Yonekura, Y. Okamoto, D. Sakurai, S. Horiguchi, T. Hanazawa, and A. Nakano Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children Allergol Int 59 4 2010 Dec 381 388
23. A. Yukselen, S.G. Kendirli, M. Yilmaz, D.U. Altintas, and G.B. Karakoc Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study Int Arch Allergy Immunol 157 3 2012 288 298
24. M. Penagos, E. Compalati, F. Tarantini, R. Baena-Cagnani, J. Huerta Lopez, and G. Passalacqua Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years age: a meta-analysis of randomized, placebo-controlled double-blind trials Ann Allergy Asthma Immunol 97 2 2006 141 148
25. D.R. Wilson, M.T. Lima, and S.R. Durham Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis Allergy 60 1 2005 Jan 4 12 Review
26. S.M. Walker, S.R. Durham, S.J. Till, G. Roberts, C.J. Corrigan, S.C. Leech British Society for Allergy and Clinical Immunology Immunotherapy for allergic rhinitis Clin Exp Allergy 41 9 2011 Sep 1177 1200
27. M.A. Calderón, T.B. Casale, A. Togias, J. Bousquet, S.R. Durham, and P. Demoly Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond J Allergy Clin Immunol 127 1 2011 Jan 30 38
28. R.K. Bush, C. Swenson, B. Fahlberg, M.D. Evans, R. Esch, and M. Morris House dust mite sublingual immunotherapy: results of a US trial J Allergy Clin Immunol 127 4 2011 Apr 974 981
29. M.A. Calderon, M. Penagos, A. Sheikh, G.W. Canonica, and S.R. Durham Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis Clin Exp Allergy 41 9 2011 Sep 1263 1272
30. C. Ozdemir, D. Yazi, I. Gocmen, and O. Yesil Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma Pediatr Allergy Immunol 18 6 2007 508 515
31. S.H. Choi, Y. Yoo, J. Yu, C.S. Rhee, Y.G. Min, and Y.Y. Koh Bronchial hyperresponsiveness in young children with allergic rhinitis and its risk factors Allergy 62 9 2007 Sep 1051 1056
32. M. Marogna, M. Bruno, A. Massolo, and P. Falagiani Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: a long-term (13-year) retrospective study in real life Int Arch Allergy Immunol 142 1 2007 70 78
33. C.E. Pichler, A. Helbling, and W.J. Pichler Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity Allergy 56 2001 301 306
34. G.B. Pajno, D. Vita, S. Parmiani, L. Caminiti, S. La Grutta, and G. Barberio Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate Clin Exp Allergy 33 12 2003 Dec 1641 1647
35. C.A. Akdis, I.B. Barlan, N. Bahceciler, and M. Akdis Immunological mechanisms of sublingual immunotherapy Allergy 61 Suppl. 81 2006 11 14
36. J.N. Francis, L.K. James, and G. Paraskevopoulos Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity J Allergy Clin Immunol 121 5 2008 1120 1125